Showing results (51-60 of 157) with videos related to
Sort By:
Pageof 16
Haematologica|August 6, 2002
A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromesGuillermo Garcia-Manero, Stefan Faderl, Francis Giles, et al.Cancer|March 13, 2009
Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Farhad Ravandi, et al.Cancer|October 11, 2008
Outcome of adults with acute lymphocytic leukemia after second salvage therapySusan O'Brien, Deborah Thomas, Farhad Ravandi, et al.Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemiaYesid Alvarado, Apostolia Tsimberidou, Hagop Kantarjian, et al.Leukemia & Lymphoma|January 19, 2010
Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remissionHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.Journal of Pediatric and Adolescent Gynecology|August 5, 2023
A Multimodal Qualitative Approach to Understanding Menstrual Health Equity among Adolescents and Young AdultsShelby Davies, Kaja Darien, Farnaz Bazyar, et al.Pharmacoepidemiology and Drug Safety|December 25, 2010
Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic usersElaine H Morrato, Benjamin G Druss, Daniel M Hartung, et al.Cancer|August 26, 2010
Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission durationHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.Leukemia & Lymphoma|February 28, 2007
A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phaseAlfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, et al.Cancer|September 13, 2007
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failureJorge Cortes, Alfonso Quintás-Cardama, Guillermo Garcia-Manero, et al.Pageof 16